查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2022-2029 年全球高级伤口护理市场
市场调查报告书
商品编码
1143387

2022-2029 年全球高级伤口护理市场

Global Advanced Wound Care Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

高级伤口护理市场规模预计将在 2021 年达到 103.189 亿美元，在预测期间（2022-2029 年）以 4.90% 的复合年增长率增长。

Advanced Wound Care 包括治疗急性和慢性伤口的产品，例如溃疡、烧伤和手术后伤口。薄膜和泡沫敷料、水凝胶、藻酸盐和水胶体等产品可保持伤口水合以促进癒合而不阻塞伤口。该市场通过提供易于获得且价格合理的产品来为患有慢性伤口的患者提供解决方案，以方便他们使用。先进的伤口护理管理市场报告还涵盖了各种竞争技术，如先进的伤口敷料技术、有害压力伤口护理 (NPWT)、生物製剂/生物活性产品和高压氧治疗设备。

市场动态

推动市场增长的主要因素包括老龄化社会、技术进步、糖尿病患者增加、患者意识提高以及患者医疗费用增加。

增加与伤口护理相关的研究和投资活动预计将推动市场增长

正在进行的研究活动的存在预计将推动伤口护理市场。例如，2018 年 12 月，麦吉尔大学健康中心 (MUHC) 和麦吉尔大学的一项新研究发现，使用名为 Swift Skin and Wound 的新应用程序可以准确测量皮肤瑕疵并绘製其进展情况，可用于临床实践。它被证明具有显着影响管理和患者结果的潜力。该应用程序目前正在蒙特利尔麦吉尔大学健康中心 (MUHC) 的临床医生和医疗保健专业人员使用。

此外，根据俄亥俄州立大学研究人员团队最近在 2019 年 3 月在线发表在《科学报告》上的一项研究，电整流绷带可以杀死伤口周围的细菌，帮助伤口更快癒合。说。 ipLine Medical, Inc（加利福尼亚州坎贝尔）筹集了 1200 万美元的 E 轮融资，以支持 Zip 手术皮肤闭合产品的全球商业化和先进工具的开发，以降低捆绑式护理环境中的成本。这笔资金得到了新投资者 HighCape Partners（纽约州纽约市）和现有投资者 MVM Life Science Partners LLP（马萨诸塞州波士顿）的支持。该公司在开发具有成本效益的非侵入性手术皮肤闭合器方面具有创新地位，可提高手术效率和患者满意度。该公司的旗舰产品是一种外科皮肤闭合装置，已被美国食品和药物管理局 (FDA) 列为 I 类 510(k) 豁免。

与伤口护理产品相关的高成本是阻碍市场增长的关键因素之一

根据英国国民健康服务 (NHS) 的数据，静脉性腿部溃疡 (VLU)、压力性溃疡 (PU) 和 DFU 是英国最昂贵的伤口之一。英国的一项研究估计，这些伤口护理的成本超过 45 亿英镑（57.2 亿美元），这还不包括合併症的护理和患者自身的成本。除了抗微生物敷料（银、碘、蜂蜜）之外，没有比非药物敷料更适合用于慢性伤口癒合的坚固且具有成本效益的敷料。

此外，伤口护理产品的处方量很大，并根据需要使用，这增加了成本。与传统的伤口敷料相比，高级伤口护理产品价格昂贵。因此，儘管癒合缓慢，许多患者仍选择传统敷料。这对高级伤口敷料领域的发展构成了重大挑战。在美国，治疗慢性伤口的费用非常高，每次治疗费用从 2,000 美元到 10,000 美元不等，具体取决于症状和护士费用。在美国，管理压疮的费用估计为 7,000 至 55,000 美元，所有治疗的年费用估计为数十亿日元。

COVID-19 影响分析

COVID-19 的爆发将在预测期的早期影响高级伤口护理市场。由于全国范围内的停工、伤口护理服务被拒绝、择期手术的取消或推迟等，预计高级伤口护理市场在预测期内将出现一定的下降。由于病毒的传播，高级伤口护理市场的许多公司被迫暂停生产和生产运营。此外，新的政府法规正在暂停业务，这对高级伤口护理市场的盈利动态产生了直接影响。医院门诊部 (HOPD) 伤口诊所一直是治疗这些伤口的主要护理场所，但在最初的 COVID 激增期间关闭了其中一些设施，许多慢性伤口患者无法看医生，延误治疗，并搬到医生办公室接受治疗。英国已经取消了超过 200 万次非紧急程序，以腾出医疗资源来抗击这一流行病。同样，在宣布冠状病毒大流行后，美国医院的就诊人数下降了 30-60%。事实上，有一些证据表明，自大流行开始以来，伤口严重程度有所增加，更复杂产品的使用有所增加，不幸的是，截肢人数有所增加。

行业分析

全球高级伤口护理市场基于波特五力、监管分析、报销分析、供应链分析、定价分析和技术进步等各种行业因素对市场进行了深入分析。 .

细分分析

预计渗出液管理部门将在全球先进伤口护理市场中占据最大的市场份额

渗出液是从伤口渗出的液体，在癒合过程中起着重要作用。渗出物主要是水，但也包含营养物质、蛋白质、废物和各种细胞类型，如血小板和巨噬细胞。渗出液管理对于避免患者因伤口引起的明显疼痛、不适和痛苦、为伤口癒合创造最佳环境以及防止感染风险至关重要。

但是，在慢性伤口中，渗出液会对伤口癒合产生不利影响。渗出液，尤其是来自慢性伤口的渗出液，含有多种元素（细胞碎片和□），它们对伤口床和伤口周围完整的皮肤都具有高度腐蚀性。渗出液管理是护理慢性伤口患者的医疗保健专业人员面临的最大挑战之一。湿伤口管理在敷料材料和护理时间方面成本高昂，但在当前的医疗经济环境下，我们更注重降低成本。

区域分析

北美在全球医疗保健 IT 市场中占有最大的市场份额。

由于产品创新、糖尿病患者发病率上升、医疗保健支出上升以及该地区人口老龄化的增长，北美在 2019 年主导全球高级伤口护理市场，预计在 ( 2020-2027）。预计该地区伤口病例的增加将提振市场。例如，美国国立卫生研究院估计，65 岁以上的人口中有 3% 最终会出现伤口。由于创伤和溃疡在资源贫乏国家和其他地方的地方性，预计发病率会更高。因此，越来越多的伤口正在推动市场。

预计该地区主要参与者对伤口管理的持续研究活动将提振市场。 Cedars-Sinai Health System 等人的 Brennan Spiegel 于 2019 年 8 月 14 日在开放获取期刊 PLOS ONE 上发表的一项研究发现，治疗性虚拟现实 (VR) 可以减轻伤口护理和焦虑症期间的疼痛。已被证明正在成为一种积极的非药物治疗方式，用于分散患者的注意力。因此，正在进行的研究活动的存在推动了市场。在该地区，开发伤口护理产品的主要参与者的存在预计将推动市场发展。例如，2019 年 3 月 4 日，Organogenesis Holdings Inc. 宣布其 PuraPly Antimicrobial (PuraPly AM) 产品对一系列先前对治疗无反应的复杂慢性伤口的癒合过程产生了积极影响。因此，市场受到主要参与者推出各种伤口护理产品的推动。

值得关注的重点公司

3M 医疗保健

概览 3M Healthcare 製造、采购和销售医疗、口腔护理和药物输送产品。该公司开发支持重症监护和慢性病预防和治疗的产品和解决方案。感染预防解决方案是一个健康信息系统，可降低患者和医护人员暴露于医疗相关感染的风险，并支持健康信息的彙编和利用。 3M Healthcare 作为 3M 的子公司运营，为製药和生物技术公司提供吸入、透皮、微针、口服和局部给药技术，以提高临床和财务业绩。

我们还为医疗设备製造商提供正畸解决方案、伤口护理解决方案、手术设备、消费者健康、微流体、医用胶带和粘合剂技术。

产品组合 PREVENA 疗法 - 专为增强切口管理而设计，可在 SARS-CoV-2 爆发期间保护患者、外科医生、工作人员、诊所和医院。

全球高级伤口护理市场报告提供对大约 45 多个市场数据表、40 多个数字和 180 页的访问。

内容

第1章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第 4 章市场动态

  • 市场影响因素
  • 驱动程序
    • 启动与伤口护理相关的研究和投资活动
  • 约束因素
    • 与伤口护理产品相关的高成本
  • 机会
  • 影响分析

第5章产业要素

  • 波特的五种力量
  • 监管机构分析
  • 供应链分析
  • 报销分析
  • PEST 分析
  • 定价分析

第 6 章按产品分类

  • 渗出液管理
    • 水凝胶
    • 泡沫
    • 硅胶敷料
      • 硅光敷料
      • 硅胶吸水敷料
      • 硅胶片
    • 水胶体
    • 海藻酸盐
    • 超强吸水性
  • 传染病对策
    • 银伤口敷料
    • 胶原蛋白敷料
    • 非银敷料
  • 皮肤替代品
    • 异种移植
    • 异体移植
    • 胎盘/羊水组织
    • 生物工程皮肤/人工替代品
  • 治疗设备
    • 负压伤口护理装置（NPWT 装置）
      • 传统负压伤口治疗 (NPWT)
      • 泵
      • 罐
      • 梳妆台
      • 一次性使用负压伤口治疗 (NPWT)
    • 高压氧治疗仪
    • 超声波喷雾/电刺激器
  • 加压绷带
    • 完全压缩 - 2 层
    • 其他
  • 止血材料
  • 纳米纤维敷料

第 7 章按伤口类型

  • 慢性伤口
    • 压疮（PU）
    • 下肢静脉溃疡 (VLU)
    • 糖尿病足溃疡 (DFU)
  • 急性伤口

第 8 章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 意大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 9 章竞争格局

  • 竞争场景
  • 市场情况/份额分析
  • 併购分析

第 10 章公司简介

  • 3M 医疗保健
    • 公司简介
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • Urgo Medical
  • B. Braun Medical
  • Coloplast A/s
  • ConvaTec Inc
  • Derma Sciences, Inc
  • Paul Hartmann AG
  • Smith & Nephew
  • Medline Industries, Inc.
  • Acelity
  • Molnlycke Healthcare
  • Oranogenesis

第11章 全球高级伤口护理市场-DataM

简介目录
Product Code: DMHCIT586

Market Overview

The Advanced Wound Care Market size was valued US$ 10,318.90 million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 4.90% during the forecast period (2022-2029).

Advanced wound care comprises products that treat acute and chronic wounds, such as ulcers, burns, and post-operative wounds. The products, such as film and foam dressings, hydrogels, alginates, and hydrocolloids, keep the damage hydrated to encourage healing without occluding the wound. The market offers solutions to patients suffering from chronic wounds by providing them with readily reachable and priced products that can be used at their convenience. The advanced wound care management market report also covers various competing technologies, such as advanced wound dressing technologies, harmful pressure wound therapies (NPWT), biologics/bioactive products, and hyperbaric oxygen therapy devices.

Market Dynamics

The growth of the market is majorly driven by increasing aging population, advancements in technologies, raising prevalence of diabetics, increasing patient awareness, raising patient healthcare expenditure are the major factors driving the growth of the market

Rising research & investment activities related to wound care are expected to drive market growth

The presence of ongoing research activities is expected to boost the wound care market. For instance, in December 2018, according to new research from the McGill University Health Centre (MUHC) and McGill University showed the use of a new application, called Swift Skin and Wound, which measures accurately and charts the progression of skin wounds, could potentially have a significant impact on the clinical management and the patient outcomes. Clinicians and healthcare professionals are currently using the app at the McGill University Health Centre (MUHC) in Montreal.

Also, in March 2019, according to a study, published online recently in the journal Scientific Reports by a research team at the Ohio State University, stated that the electroceutical bandages could kill the bacteria around a wound, allowing the wounds to heal faster. ipLine Medical, Inc (Campbell, CA), completed a $12 million Series E round of financing to support the worldwide commercialization activities for the Zip Surgical Skin Closure product and the development of advanced tools for reducing costs in a bundled care environment. Financing was backed by a new investor, HighCape Partners (New York, NY), and existing investor MVM Life Science Partners LLP (Boston, MA). The company is an innovator in developing cost-effective, noninvasive surgical skin closure devices that improve surgical efficiency and patient satisfaction. Its leading surgical skin closure product is classified by the United States Food and Drug Administration as Class I, 510(k) Exempt.

The high cost associated with the wound care products is one of the major factors hindering the growth of the market

According to the National Health Service (NHS) in the United Kingdom, venous leg ulcers (VLUs), pressure ulcers (PUs) and DFUs are among the costliest wounds in UK. According to a UK-based study, the cost of these wound care was estimated at over £4.5 billion (5.72 USD billion), not accounting for the care of comorbidities or costs undertaken by patients themselves. No robust or cost-effective dressing is available except antimicrobial dressings (silver, iodine, or honey), which are preferred over nonmedicated dressings to heal chronic wounds.

Moreover, wound care products are prescribed in large quantities for use on an as-needed basis, which incurs additional cost. Advanced wound care products are expensive compared to traditional wound dressing techniques. Therefore, many patients opt for traditional dressings despite its slow healing process. This is posing a major challenge for the growth of the advanced wound dressings segment. The cost of treating chronic wounds in the U.S. is extremely high, with the charge per case ranging from $2,000 to $10,000 depending upon the condition and nursing costs. The cost of managing a pressure ulcer is estimated to be between $7,000 and $55,000 in the U.S., while the annual cost of all treatment is valued in billions.

COVID-19 Impact Analysis

The COVID-19 outbreak will impact the advanced wound care market in the initial phase of the forecast period. Due to nationwide lockdowns, denied wound care services and cancelled or postponed elective surgeries, the advanced wound care market is expected to register a certain decline during the forecast period. Many companies in the advanced wound care market are forced to halt their manufacturing and production operations, owing to spread of the virus. Moreover, business operations have been paused, owing to new government rulings, which directly influences revenue drift of the advanced wound care market. The hospital outpatient department (HOPD) wound clinics have been the primary site-of-care to treat these wounds but with the closing of several of these facilities during the initial COVID surge, many patients with chronic wounds were not seen, delayed treatment or began the transfer to the physician office for treatment. More than two-million non-emergency procedures were cancelled in the UK to free up healthcare resources to help fight against the pandemic. Similarly, the hospitals in the USA saw a 30-60% decline in hospital visits after the announcement of coronavirus as a pandemic. In fact, there is some evidence that wounds increased in severity since the start of the pandemic resulting in greater use of higher technology products and unfortunately, an increase in amputations.

Industry Analysis

The global advanced wound care market provides in-depth analysis of the market based on various industry factors such as porter's five forces, regulatory analysis, reimbursement analysis, supply chain analysis, pricing analysis, technological advancements etc.

Segment Analysis

Exudate management segment is expected to hold the largest market share in global advanced wound care market

Exudate is the fluid leaking from the wound, which has a vital role in the healing process. It is mainly water but also consists of nutrients, proteins, waste products and various types of cells such as platelets and macrophages. Exudate management is essential as it avoids significant pain, discomfort and suffering of the patient due to wounds; helps create an optimal environment for wound healing; and, prevents the risk of infection.

In chronic wounds, however, the exudate produced can be detrimental to the process. Wound exudate, particularly from chronic wounds, contains a cocktail of elements (cellular debris and enzymes), which can be highly corrosive, both to the wound bed and intact skin surrounding the wound. For the health professional caring for patients with chronic wounds, controlling exudate can be one of the biggest challenges. Managing wet wounds is costly in terms of dressing materials and nursing time and in the current economic climate within health care we are more than eve aware of reducing costs.

Geographical Analysis

North America region holds the largest market share in the global healthcare IT market

North America is dominating the global advanced wound care market in 2019 and estimated to hold significant market size over the forecast period (2020-2027) owing to the product innovations, rise in the incidence of diabetes cases, increasing healthcare spending and the growing aging population in this region. The increasing number of wound cases in the region are expected to boost the market. For instance, the National Institute of Health has estimated that 3% of the population of 65 years and above would have a wound at some time. An even higher rate of incidence is expected, owing to the traumatic injuries and ulcers endemic in resource-poor countries to other regions. Thus, the rising number of wounds is driving the market.

The ongoing research activities for wound management by the key players in the region is expected to boost the market. According to a study published on August 14, 2019, in the open-access journal PLOS ONE by Brennan Spiegel of Cedars-Sinai Health System and colleagues found that therapeutic virtual reality (VR) is emerging as an active, non-pharmacological treatment modality for pain, anxiety disorders, and distract patients during wound care. Thus, the presence of ongoing research activities is driving the market. The presence of key players developing wound care products in the region are expected to boost the market. For instance, on March 04, 2019 Organogenesis Holdings Inc. announced that PuraPly Antimicrobial (PuraPly AM) product has positively affected the course of healing in a variety of complex, chronic wounds that were previously unresponsive to treatment. Thus, the presence of key players launching different wound care products are driving the market.

Competitive Landscape

The advanced wound care market is highly competitive, owing to the presence of big brands. Also, the market is highly fragmented due to the presence of several large and regional players. The key players which are contributing to the growth of the global market include 3M Healthcare, Urgo Medical, B. Braun Medical, Coloplast A/s, ConvaTec Inc, Derma Sciences, Inc., Paul Hartmann AG, Smith & Nephew, Medline Industries, Inc., Acelity, Molnlycke Healthcare, Oranogenesis.

Key Companies to Watch

3M Health Care:

Overview: 3M Health Care Limited manufactures, procures, and markets medical, oral care, and drug delivery products. The company develops critical and chronic care products and solutions that help prevent and treat critical and chronic conditions across the continuum of care infection prevention solutions to reduce the risk of exposure to healthcare-associated infections for patients and healthcare professionals' health information systems to help compile and use health information. 3M Health Care Limited operates as a subsidiary of 3M Company for better clinical and financial performance inhalation, transdermal, micro needle, or oral and topical drug delivery technologies for pharmaceutical and biotechnology companies.

The company also offers orthodontic solutions, wound care solutions, surgical devices, consumer health, micro fluidics, medical grade tapes and adhesive technologies to medical device manufacturers.

Product Portfolio: PREVENA Therapy- It is uniquely engineered to empower incision management that works to protect patients, surgeons, staff, practices, and hospitals during the SARS-CoV-2 pandemic.

The global advanced wound care market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
  • 4.2. Drivers
    • 4.2.1. Rising research & investment activities related to wound care
  • 4.3. Restraints
    • 4.3.1. The high cost associated with the wound care products
  • 4.4. Opportunities
  • 4.5. Impact Analysis

5. Industry Factors

  • 5.1. Porter's Five Forces
  • 5.2. Regulator Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Reimbursement Analysis
  • 5.5. PEST Analysis
  • 5.6. Pricing Analysis

6. By Product

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 6.1.2. Market Attractiveness Index, By Product
  • 6.2. Exudate Management*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 6.2.3. Hydrogel
    • 6.2.4. Foam
    • 6.2.5. Silicone Dressing
      • 6.2.5.1. Silicone Lite Foam Dressing
      • 6.2.5.2. Silicone absorbent dressings
      • 6.2.5.3. Silicone gel sheets
    • 6.2.6. Hydrocolloids
    • 6.2.7. Alginate
    • 6.2.8. Super Absorbent
  • 6.3. Infection Management
    • 6.3.1. Silver Wound Dressing
    • 6.3.2. Collagen Dressing
    • 6.3.3. Non-Silver Dressing
  • 6.4. Skin Substitutes
    • 6.4.1. Xenograft
    • 6.4.2. Allograft
    • 6.4.3. Placenta/Amniotic Tissue
    • 6.4.4. Bioengineered skin/synthetic Substitutes
  • 6.5. Therapy Devices
    • 6.5.1. Negative Pressure Wound Therapies (NPWT Devices)
      • 6.5.1.1. Conventional Negative Pressure Wound Therapy (NPWT)
      • 6.5.1.1.1. Pumps
      • 6.5.1.1.2. Canisters
      • 6.5.1.1.3. Dressing Kits
      • 6.5.1.2. Single-Use Negative Pressure Wound Therapy (NPWT)
    • 6.5.2. Hyperbaric Oxygen Therapy
    • 6.5.3. Ultrasonic Mist and Electrical Stimulation Devices
  • 6.6. Compression Bandage
    • 6.6.1. Full Compression - 2 layers
    • 6.6.2. Others
  • 6.7. Hemostatic Dressing
  • 6.8. Nanofibre Dressing

7. By Wound Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound Type
    • 7.1.2. Market Attractiveness Index, By Wound Type
  • 7.2. Chronic Wounds*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 7.2.3. Pressure Ulcer (PU)
    • 7.2.4. Venous Leg Ulcer (VLU)
    • 7.2.5. Diabetic Foot Ulcer (DFU)
  • 7.3. Acute Wounds

8. By Region

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound Type
    • 8.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.2.5.1. The U.S.
      • 8.2.5.2. Canada
      • 8.2.5.3. Mexico
  • 8.3. South America
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound Type
    • 8.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.3.5.1. Brazil
      • 8.3.5.2. Argentina
      • 8.3.5.3. Rest of South America
  • 8.4. Europe
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound Type
    • 8.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.4.5.1. Germany
      • 8.4.5.2. The U.K.
      • 8.4.5.3. France
      • 8.4.5.4. Spain
      • 8.4.5.5. Italy
      • 8.4.5.6. Rest of Europe
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound Type
      • 8.5.4.1. China
      • 8.5.4.2. India
      • 8.5.4.3. Japan
      • 8.5.4.4. Australia
      • 8.5.4.5. Rest of Asia-Pacific
  • 8.6. Middle East & Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound Type

9. Competitive Landscape

  • 9.1. Competitive Scenario
  • 9.2. Market Positioning/Share Analysis
  • 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

  • 10.1. 3M Healthcare
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio and Description
    • 10.1.3. Key Highlights
    • 10.1.4. Financial Overview
  • 10.2. Urgo Medical
  • 10.3. B. Braun Medical
  • 10.4. Coloplast A/s
  • 10.5. ConvaTec Inc
  • 10.6. Derma Sciences, Inc
  • 10.7. Paul Hartmann AG
  • 10.8. Smith & Nephew
  • 10.9. Medline Industries, Inc.
  • 10.10. Acelity
  • 10.11. Molnlycke Healthcare
  • 10.12. Oranogenesis

LIST NOT EXHAUSTIVE

11. Global Advanced Wound Care Market - DataM

  • 11.1. Appendix
  • 11.2. About Us
  • 11.3. Contact Us